Rezultati - Charles W. Abbottsmith
- Showing 1 - 5 results of 5
-
1
-
2
A randomized controlled trial of intravenous tissue plasminogen activator and early intravenous heparin in acute myocardial infarction. od Eric J. Topol, Barry S. George, Dean J. Kereiakes, D C Stump, Richard J. Candela, Charles W. Abbottsmith, L Aronson, Ann Pickel, Jane Boswick, K L Lee
Izdano 1989Artigo -
3
Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. TAMI Study Group. od E. Magnus Ohman, Robert M. Califf, Eric J. Topol, Richard J. Candela, Charles W. Abbottsmith, Stephen G. Ellis, Kristina N. Sigmon, Dean J. Kereiakes, Barry George, Richard S. Stack
Izdano 1990Artigo -
4
Hemorrhagic complications associated with the use of intravenous tissue plasminogen activator in treatment of acute myocardial infarction od Robert M. Califf, Eric J. Topol, Barry S. George, Jane Boswick, Charles W. Abbottsmith, Kristina N. Sigmon, Richard J. Candela, Ramona Masek, Dean J. Kereiakes, William W. O’Neill, Richard S. Stack, D C Stump
Izdano 1988Artigo -
5
Pharmacodynamic Efficacy, Clinical Safety, and Outcomes After Prolonged Platelet Glycoprotein IIb/IIIa Receptor Blockade With Oral Xemilofiban od Dean J. Kereiakes, Neal S. Kleiman, James J. Ferguson, A.R. Zaki Masud, Thomas M. Broderick, Charles W. Abbottsmith, John Paul Runyon, Linda C. Anderson, Robert J. Anders, Roger J. Dreiling, Gary Hantsbarger, Brian Bryzinski, Eric J. Topol
Izdano 1998Artigo
Iskalna orodja:
Sorodne teme
Internal medicine
Medicine
Myocardial infarction
Cardiology
Tissue plasminogen activator
Anesthesia
Aspirin
Ejection fraction
Heart failure
Surgery
Abciximab
Alternative medicine
Angioplasty
Artery
Bolus (digestion)
Environmental health
Fibrinolysis
Hematocrit
Heparin
Intensive care medicine
Interquartile range
Intravenous Infusions
Pathology
Percutaneous coronary intervention
Pharmacodynamics
Pharmacokinetics
Pharmacology
Placebo
Population
Randomized controlled trial